Research
Cellular
Atherogenic dyslipidemias are a major contributor to ASCVD within the CKM framework.
Recognize and address dyslipidemias in patients with obesity to mitigate cardiovascular disease risk.
StrongSupportsmedium confidence
Atherogenic dyslipidemias are a hallmark of high-risk obesity phenotypes and a major contributor to ASCVD within the CKM framework.
Why this rating
The claim is supported by a comprehensive review of existing literature.
Source
Obesity phenotypes and atherogenic dyslipidemias
Hun Jee Choe et al. · European Journal of Clinical Investigation · 2025
DOI 10.1111/eci.70151
reviewCited 4×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Cellular
- Athletes aiming to reduce fat mass and preserve FFM should consume protein intakes in the range of ∼1.8-2.7 g kg(-1) d(-1).Strong
- A minimum daily protein intake of ≥1.6 g/kg is necessary to observe significant improvements in muscle mass from whey protein supplementation.Strong
- Most athletes ideally need 1.2 to 2.0 grams/kg of body weight/day of protein, preferably split across 3-4 meals.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →